GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation ...

A study by Cleveland Clinic and USC researchers long-term risk associated with COVID-19 “continues to pose a significant ...

Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A new study says that type 2 diabetes medications GLP-1 agonists and SGLT2 inhibitors may help lower a stroke survivor’s risk of experiencing a subsequent stroke, heart attack, or death ...

A heart attack and stroke are both serious health conditions that occur when there's a blockage in the arteries (blood vessels). This blockage causes a reduction in proper blood flow to the heart ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death ...

Sleep deprivation has become a common problem several people face on a daily basis. But, it may put you at risk of heart ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...